Earnings calls

Unichem Labs. concall ledger

Every earnings call for UNICHEMLAB — management tone, guidance, KPIs and promise tracking, quarter by quarter.

UNICHEMLAB · 5 transcripts · Healthcare · latest Q3 FY17

Q3 FY17Published 23 Jan 2017Call held 23 Jan 2017

UNICHEMLAB Q3 FY17 Earnings Call Transcript & Analysis

Revenue₹360 cr+16% YoYEBITDA₹44.4 cr+30% YoYPAT₹26 cr+30% YoYEPS₹2.87+26% YoY

Revenue (Q3 FY17) ₹360 cr (+16% YoY); EBITDA (Q3 FY17) ₹44 cr (+30% YoY); PAT (Q3 FY17) ₹26 cr (+30% YoY). Q3 FY17 Revenue stood at Rs. 360 Crores, marking a 16% year-on-year growth.

Read full transcript & analysis

Q2 FY17Published 24 Oct 2016Call held 24 Oct 2016

UNICHEMLAB Q2 FY17 Earnings Call Transcript & Analysis

Standalone Revenue227 Crores+18% YoYEBITDA39.6 Crores+15% YoY

Standalone Revenue (Q2 FY17) 227 Crores (+18% YoY); EBITDA (Q2 FY17) 39.6 Crores (+15% YoY). Total income from operations for Q2 FY17 was Rs. 368 Crores, marking a 19% YoY growth.

Read full transcript & analysis

Q1 FY17Published 25 Jul 2016Call held 25 Jul 2016

UNICHEMLAB Q1 FY17 Earnings Call Transcript & Analysis

EBITDA44 Crores

EBITDA 44 Crores. Total income from operations grew by 9.5% to Rs. 342 Crores.

Read full transcript & analysis

Q4 FY16Published 23 May 2016Call held 23 May 2016

UNICHEMLAB Q4 FY16 Earnings Call Transcript & Analysis

Consolidated EBITDA₹164 cr+62% YoYConsolidated EBITDA Margin12.28%Consolidated Net Profit₹111 cr

Consolidated EBITDA ₹164 cr (+62% YoY); Consolidated EBITDA Margin 12.28%; Consolidated Net Profit (pre-exceptional) ₹111 cr. Consolidated FY16 Income from Operations grew 11% to Rs. 1335 Crores.

Read full transcript & analysis

Q3 FY16Published 25 Jan 2016Call held 25 Jan 2016

UNICHEMLAB Q3 FY16 Earnings Call Transcript & Analysis

EBITDA₹34 crNet Profit₹23 cr

EBITDA ₹34 cr; Net Profit ₹23 cr. Q3 FY16 Turnover stood at Rs.306.3 Crores.

Read full transcript & analysis